# The Better Meat Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/the-better-meat

- Industry: Food
- Headquarters: US
- Website: www.bettermeat.co
- Total disclosed funding: $39M
- Latest round: Series A (Aug 19, 2025)
- Investors on record: 8

## About

The Better Meat Co. is a US-based company specializing in the production of Rhiza mycoprotein, a clean-label ingredient derived from fungi. The company focuses on creating healthier and sustainable plant-based food solutions.Founded in 2018 by Gus Pattillo, Joanna Bromley, and Paul Shapiro, The Better Meat Co. produces Rhiza mycoprotein, which serves as both a meat enhancer and a standalone protein source. The company is headquartered in the United States and has closed 3 funding deals. In August 2025, The Better Meat Co. raised USD 31 million in series A funding co-led by new investors Future Ventures and Resilience Reserve, with participation from other new investors EPIC Ventures and Sigmas Group. Individual and other unspecified investors also participated in the round. The Better Meat Co. specializes in producing Rhiza mycoprotein, a versatile and clean-label ingredient derived from mycelium. Rhiza is positioned as an all-natural, single-ingredient, whole food that serves as both a meat enhancer and a standalone protein source suitable for a variety of food applications. It offers a complete amino acid profile and boasts higher protein and fiber content compared to traditional meat products and other plant-based proteins. Rhiza targets food manufacturers, including restaurants and grocery chains, facilitating the development of healthier, plant-based, or meat-enhanced food items. The company's clientele includes partners such as Perdue Farms and local restaurants in the Sacramento region, with products marketed across the United States.The Better Meat Co. generates revenue through business-to-business partnerships, supplying Rhiza mycoprotein to food manufacturers and food service providers. The revenue model is based on bulk sales of Rhiza mycoprotein, with a focus on establishing long-term contracts to ensure consistent supply and pricing stability. Clients incorporate Rhiza into their offerings, enhancing nutritional profiles and meeting market demand for healthier food options, with pricing tailored to individual client needs based on volume requirements and product applications. The company plans to use the August 2025 funding to accelerate its fermentation technology and production. The company is designing additional Rhiza-based products aimed at increasing its market presence. Furthermore, it intends to target expansion within the North American food market by mid-2023, focusing on partnerships with regional food manufacturers and exploring opportunities in international markets.

## Funding rounds

- Series A, Aug 19, 2025, $31M — EPIC Ventures, Future Ventures, Sigmas Group, Resilience Reserve
- Seed, Jul 28, 2020, $2.5M — Lever VC, Greenlight Capital Inc., Johnsonville Ventures, Green Circle Capital Partners
- Seed, Jan 1, 2020, $5.6M — Lever VC

## Investors

- Lever VC (https://capitalatlas.ai/funds/lever-vc) — Seed
- Greenlight Capital Inc. — Seed
- Johnsonville Ventures (https://capitalatlas.ai/funds/johnsonville-ventures) — Seed
- Green Circle Capital Partners (https://capitalatlas.ai/funds/green-circle-capital-partners) — Seed
- EPIC Ventures (https://capitalatlas.ai/funds/epic-ventures) — Series A
- Future Ventures — Series A
- Sigmas Group — Series A
- Resilience Reserve (https://capitalatlas.ai/funds/resilience-reserve) — Series A